- MSK’s Retinoblastoma Program is 100 years old this year. Retinoblastoma is a rare eye cancer found in the pediatric population. An effective treatment for this once fatal disease was developed at MSK in 2006. The treatment is safe, can be performed in the outpatient setting and causes no side effects in most patients.
- The groundbreaking for a new MSK facility in Middletown, NJ took place on Thursday, September 18, 2014. Outpatient cancer treatment will be offered including surgery. Clinical trials will also be carried on. Cancer patients from Monmouth, Middlesex and Ocean counties will benefit from receiving care close to their homes.
- An MSK study has shown that cancer patients who use e-cigarettes along with regular cigarettes to try to stop smoking, are not more likely to quit than non-users. Dr. Jamie Ostroff who leads MSK’s smoking cessation program, said there are questions about the long-term safety and effectiveness of e-cigarettes.